GLP1R and neoplasm: Despite these efforts, a GLP-1R-antagonist radioligand based on Ex(9-39) has not yet made it to clinical practice as a diagnostic or therapeutic agent due to low tumor uptake, rapid washout from tumor-sites, or lack of affinity to the human GLP-1R.